OptimizeRx Corp (OPRX) earnings
Quarterly results of OptimizeRx Corp as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
OptimizeRx Corp was expected to report around November 5, 2026; nothing is on file with the SEC yet.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) OptimizeRx Corp reported revenue of $20.5M (-29.8% on the same quarter a year earlier) and a net loss of $703K.
Diluted earnings per share were -$0.04.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | $20.5M | -29.8% | -$703K | -$0.04 |
| Q1 FY2026 | $19.8M | -9.5% | -$495K | -$0.03 |
| Q4 FY2025 | $32.2M | -0.2% | $5M | - |
| Q3 FY2025 | $26.1M | +22.3% | $779K | $0.04 |
| Q2 FY2025 | $29.2M | - | $1.5M | $0.08 |
| Q1 FY2025 | $21.9M | - | -$2.2M | -$0.12 |
| Q4 FY2024 | $32.3M | - | -$78K | - |
| Q3 FY2024 | $21.3M | - | -$9.1M | -$0.50 |
Results filings
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly results 8-K
- Annual report 10-K
- Quarterly results 8-K
- Quarterly report 10-Q
When is OptimizeRx Corp's next earnings date?
OptimizeRx Corp was expected to report around November 5, 2026; nothing is on file with the SEC yet.
What were OptimizeRx Corp's latest quarterly results?
For Q2 FY2026, which ended June 30, 2026, OptimizeRx Corp reported revenue of $20.5M and a net loss of $703K. The figures come from its filing with the SEC.
Is OptimizeRx Corp's revenue growing?
Revenue in Q2 FY2026 was $20.5M, down 29.8% from $29.2M in the same quarter a year earlier.
Get an email when OPRX reports
Follow OPRX and we email you its next results the day they are filed, with the numbers explained.